BACKGROUND: T cells that have been modified to express a CD19-specific chimeric antigen receptor (CAR) have antitumor activity in B cell malignancies; however, identification of the factors that determine toxicity and efficacy of these T cells has been challenging in prior studies in which phenotypi...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!